Montanide 51 is a water-in-oil (W/O) emulsion-based vaccine adjuvant developed by SEPPIC. It creates a stable oil-phase microenvironment that prolongs antigen retention at the injection site, enhancing antigen immunogenicity and inducing potent immune responses. Montanide ISA 51 is particularly suitable for vaccines requiring strong cellular and humoral immunity, such as cancer vaccines and therapeutic vaccines.
This adjuvant is characterized by its high immune-enhancing capacity, excellent stability, and compatibility with various antigens. Montanide ISA 51 has shown remarkable efficacy in cancer vaccine development, effectively activating antigen-specific T cell responses and promoting anti-tumor immunity. Additionally, it has been used in research for vaccines against infectious diseases, such as HIV and malaria.
In summary, Montanide ISA 51, as an efficient water-in-oil adjuvant, provides critical technical support for the development of therapeutic and cancer vaccines through its unique sustained-release mechanism and immune-enhancing properties. It is particularly effective in scenarios requiring robust cellular immune responses.
Cat.No
DC67254
Name
Montanide 51
Chemical Properties
CAS
Formula
MW
Storage
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
